Rakuten Medical Secures $100M for Cancer Treatment Development

Rakuten Medical closes $100M Series F financing round to advance investigational photoimmunotherapy drug ASP-1929 and expand global reach.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here